Anti-Cytochrome P450 1A2 抗体 [EPR6138(2)]
Anti-Cytochrome P450 1A2 antibody [EPR6138(2)]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal Cytochrome P450 1A2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.
查看别名
Cytochrome P450 1A2, CYPIA2, Cholesterol 25-hydroxylase, Cytochrome P(3)450, Cytochrome P450 4, Cytochrome P450-P3, Hydroperoxy icosatetraenoate dehydratase, CYP1A2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Cytochrome P450 1A2 with purified ab151728 at 1/200 dilution (9.4 µg/ml). Cells were fixed in 100% Methanol and permeabilized with None. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling Cytochrome P450 1A2 with purified ab151728 at 1/200 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
Overlay histogram showing MCF7 cells stained with unpurified ab151728 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab151728, 1/10000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in MCF7 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
Immunofluorescent analysis of HeLa cells labeling Cytochrome P450 1A2 with unpurified ab151728 at 1/250 dilution.
- WB
Unknown
Western blot - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
All lanes:
Western blot - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (ab151728) at 1/1000 dilution
Lane 1:
Caco2 cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
A549 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 58 kDa
false
- WB
Lab
Western blot - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (AB151728)
All lanes:
Western blot - Anti-Cytochrome P450 1A2 antibody [EPR6138(2)] (ab151728) at 1/2000 dilution
All lanes:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 58 kDa
Observed band size: 58 kDa
false
反应性数据
产品详情
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP1A2 plays a central role in the oxidative biotransformation of drugs and procarcinogens. It does not form part of a larger complex but interacts dynamically with other enzymes in the detoxification process. CYP1A2 metabolizes several clinical drugs such as caffeine and theophylline and regulates the detoxification of aromatic amines and hydrocarbons. Studying CYP1A2 inhibitors can provide insights into clinically relevant drug interactions and potential side effects in pharmacotherapy.
Pathways
CYP1A2 functions within the drug metabolism and synthesis of cholesterol steroids and other lipids pathways. In the drug metabolism pathway CYP1A2 works alongside other cytochrome P450 enzymes such as CYP1A1 and CYP1B1 which together ensure the metabolism and clearance of various exogenous and endogenous compounds. These pathways are vital for maintaining drug efficacy and preventing toxicity through the metabolic clearance of pharmaceutical agents and harmful substances.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (8)
Recent publications for all applications. Explore the full list and refine your search
Nature protocols : PubMed40715744
2025
Applications
Unspecified application
Species
Unspecified reactive species
General physiology and biophysics 44:303-315 PubMed40567073
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 24:728 PubMed38877514
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 16:969-980 PubMed34595348
2021
Applications
Unspecified application
Species
Unspecified reactive species
Drug metabolism and disposition: the biological fate of chemicals 49:361-368 PubMed33674270
2021
Applications
Unspecified application
Species
Unspecified reactive species
Hepatic medicine : evidence and research 12:79-92 PubMed32607015
2020
Applications
Unspecified application
Species
Unspecified reactive species
Hepatic medicine : evidence and research 12:15-27 PubMed32104112
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:12331 PubMed28951593
2017
Applications
WB
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com